39
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Elevated Vitamin B12, Risk of Cancer, and Mortality: A Systematic Review

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 515-526 | Received 10 Jan 2023, Accepted 08 Jun 2024, Published online: 02 Jul 2024

References

  • Bender DA. Nutritional biochemistry of the vitamins. London: Cambridge University Press; 2003.
  • Palmer AM, Kamynina E, Field MS, Stover PJ. Folate rescues vitamin B12 depletion-induced inhibition of nuclear thymidylate biosynthesis and genome instability. Proc Natl Acad Sci. 2017;114:E4095–102.
  • Sobczyńska-Malefora A, Delvin E, McCaddon A, Ahmadi KR, Harrington DJ. Vitamin B12 status in health and disease: a critical review. Diagnosis of deficiency and insufficiency–clinical and laboratory pitfalls. Crit Rev Clin Lab Sci. 2021;58(6):399–429. doi:10.1080/10408363.2021.1885339.
  • Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management. Am Fam Physician. 2017;96(6):384–389.
  • Arendt JFH, Sørensen HT, Horsfall LJ, Petersen I. Elevated vitamin B12 levels and cancer risk in UK primary care: A THIN Database Cohort Study high plasma B12 levels and cancer risk in primary care. Cancer Epidemiol Biomarkers Prev. 2019;28(4):814–821. doi:10.1158/1055-9965.EPI-17-1136.
  • Urbanski G, Hamel J-F, Prouveur B, Annweiler C, Ghali A, Cassereau J, et al. Strength of the association of elevated vitamin B12 and solid cancers: an adjusted case-control study. J Clin Med. 2020;9(2):474. doi:10.3390/jcm9020474.
  • Chiche L, Jean R, Romain F, Roux F, Thomas G, Canavese S, et al. Implications cliniques de la découverte d’une hypervitaminémie B12 en médecine interne. La Rev Médecine Interne. 2008;29:187–194.
  • Jammal M, Deneuville T, Mario N, Tiev K, Tolédano C, Josselin-Mahr L, et al. Concentration plasmatique élevée de la vitamine B12: un indicateur des maladies hépatiques ou tumorales. La Rev Médecine Interne. 2013;34:337–341.
  • Zulfiqar A-A, Andres E, Villalba NL. Hipervitaminosis B12: Nuestra experiencia y una revisión. Med (Buenos Aires). 2019;79:391–396.
  • Brah S, Chiche L, Mancini J, Meunier B, Arlet J-B. Characteristics of patients admitted to internal medicine departments with high serum cobalamin levels: results from a prospective cohort study. Eur J Intern Med. 2014;25(5):e57–8–e58. doi:10.1016/j.ejim.2014.01.014.
  • Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene. 2002;21(35):5462–5482. doi:10.1038/sj.onc.1205606.
  • Baylln SB, Herman JG, Graff JR, Vertino PM, Issa J-P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1997;72:141–196.
  • Sviri S, Khalaila R, Daher S, Bayya A, Linton DM, Stav I, et al. Increased vitamin B12 levels are associated with mortality in critically ill medical patients. Clin Nutr. 2012;31(1):53–59. doi:10.1016/j.clnu.2011.08.010.
  • Cappello S, Cereda E, Rondanelli M, Klersy C, Cameletti B, Albertini R, et al. Elevated plasma vitamin B12 concentrations are independent predictors of in-hospital mortality in adult patients at nutritional risk. Nutrients. 2016;9(1):1. doi:10.3390/nu9010001.
  • Arendt JFB, Nexo E. Unexpected high plasma cobalamin/proposal for a diagnostic strategy. Clin Chem Lab Med. 2013;51(3):489–496. doi:10.1515/cclm-2012-0545.
  • Zulfiqar AA, Sebaux A, Dramé M, Pennaforte JL, Novella JL, Andrès E. Hypervitaminemia B12 in elderly patients: frequency and nature of the associated or linked conditions. Preliminary results of a study in 190 patients. Eur J Intern Med. 2015;26(10):e63–4–e64. doi:10.1016/j.ejim.2015.09.007.
  • Andrès E, Serraj K, Zhu J, Vermorken AJM. The pathophysiology of elevated vitamin B12 in clinical practice. QJM. 2013;106(6):505–515. doi:10.1093/qjmed/hct051.
  • Xu K, Liu X, Liu J, Zhang Y, Ding X, Li L, et al. Association between serum vitamin B12 and risk of all-cause mortality in elderly adults: a prospective cohort study. BMC Geriatr. 2021;21(1):497. doi:10.1186/s12877-021-02443-z.
  • Johansson M, Appleby PN, Allen NE, Travis RC, Roddam AW, Egevad L, et al. Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study. Cancer Epidemiol Biomarkers Prev. 2008;17(2):279–285. doi:10.1158/1055-9965.EPI-07-0657.
  • Hultdin J, Guelpen BV, Bergh A, Hallmans G, Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer. 2005;113:819–824.
  • Collin SM, Metcalfe C, Refsum H, Lewis SJ, Zuccolo L, Smith GD, et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis folate, B12, and prostate. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1632–1642. doi:10.1158/1055-9965.EPI-10-0180.
  • Liu Y, Geng T, Wan Z, Lu Q, Zhang X, Qiu Z, et al. Associations of serum folate and vitamin B12 levels with cardiovascular disease mortality among patients with type 2 diabetes. JAMA Netw Open. 2022;5(1):e2146124. doi:10.1001/jamanetworkopen.2021.46124.
  • Tamayo Velasco Á, Muñoz Moreno MF, Pérez Martínez C, Martín Guerra J, Prieto DE Paula JM, Miramontes-González JP. High cobalamin levels as a five-year risk predictor for developing hematological cancer. Minerva Med. 2023;114(1):22–28. doi:10.23736/S0026-4806.22.07336-0.
  • Chen S, Honda T, Hata J, Sakata S, Furuta Y, Yoshida D, et al. High serum folate concentrations are associated with decreased risk of mortality among Japanese adults. J Nutr. 2021;151(3):657–665. doi:10.1093/jn/nxaa382.
  • Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. doi:10.1186/s13643-021-01626-4.
  • Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for. Systematic Reviews. Syst Rev. 2016;5(1):10. doi:10.1186/s13643-016-0384-4.
  • Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2000.
  • Gavars D, Perminov D, Tauckels E, Lindenberga I, Auce A, Lejniece S. Association of elevated vitamin B (12) with oncohematological diseases in a cohort of 79,524 patients from Latvia. Exp Oncol. 2019;41:357–362.
  • Arendt JFB, Pedersen L, Nexo E, Sørensen HT. Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. J Natl Cancer Inst. 2013;105(23):1799–1805. doi:10.1093/jnci/djt315.
  • Ryg J, Nybo M, Hallas J. Cancer incidence in persons with elevated cobalamin levels. Eur J Clin Invest. 2013;43(6):557–561. doi:10.1111/eci.12076.
  • Essén A, Santaolalla A, Garmo H, Hammar N, Walldius G, Jungner I, et al. Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort. Cancer Causes Control. 2019;30(6):603–615. doi:10.1007/s10552-019-01170-6.
  • Zeitlin A, Frishman WH, Chang CJ. The association of vitamin b 12 and folate blood levels with mortality and cardiovascular morbidity incidence in the old old: the Bronx aging study. Am J Ther. 1997;4(7-8):275–281. doi:10.1097/00045391-199707000-00008.
  • Callaghan FM, Leishear K, Abhyankar S, Demner-Fushman D, McDonald CJ. High vitamin B12 levels are not associated with increased mortality risk for ICU patients after adjusting for liver function: a cohort study. Espen J. 2014;9(2):e76–83–e83. doi:10.1016/j.clnme.2014.01.003.
  • Arendt JFH, Farkas DK, Pedersen L, Nexo E, Sørensen HT. Elevated plasma vitamin B12 levels and cancer prognosis: a population-based cohort study. Cancer Epidemiol. 2016;40:158–165. doi:10.1016/j.canep.2015.12.007.
  • Lacombe V, Chabrun F, Lacout C, Ghali A, Capitain O, Patsouris A, et al. Persistent elevation of plasma vitamin B12 is strongly associated with solid cancer. Sci Rep. 2021;11(1):13361. doi:10.1038/s41598-021-92945-y.
  • Rodríguez AMG, Velasco MJS, Pérez GCF, Hernández ASM, García NF, Andrade JAG. Hipervitaminosis B12 y cáncer de recto. Rev Del Lab Clínico. 2017;10:105–108.
  • Collin SM. Folate and B12 in prostate cancer. Adv Clin Chem. 2013;60:1–63. doi:10.1016/b978-0-12-407681-5.00001-5.
  • Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst. 2009;101(6):432–435. doi:10.1093/jnci/djp019.
  • de Vogel S, Meyer K, Fredriksen Å, Ulvik A, Ueland PM, Nygård O, et al. Serum folate and vitamin B12 concentrations in relation to prostate cancer risk–a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. Int J Epidemiol. 2013;42(1):201–210. doi:10.1093/ije/dys199.
  • Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, Pietinen P, Barrett MJ, Taylor PR, et al. Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. Cancer Epidemiol Biomarkers Prev. 2003;12:1271–1272.
  • Lin J, Lee I, Cook NR, Selhub J, Manson JE, Buring JE, et al. Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr. 2008;87(3):734–743. doi:10.1093/ajcn/87.3.734.
  • Zhang S, Willet W, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst. 2003;95(5):373–380. doi:10.1093/jnci/95.5.373.
  • Chang S-C, Goldstein BY, Mu L, Cai L, You N-CY, He N, et al. Plasma folate, vitamin B12, and homocysteine and cancers of the esophagus, stomach, and liver in a Chinese population. Nutr Cancer. 2015;67:212–223.
  • Lin C-Y, Kuo C-S, Lu C-L, Wu M-Y, Huang R-FS. Elevated serum vitamin B12 levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma. Nutr Cancer. 2010;62(2):190–197. doi:10.1080/01635580903305334.
  • Simonsen K, Rode A, Nicoll A, Villadsen G, Espelund U, Lim L, et al. Vitamin B12 and its binding proteins in hepatocellular carcinoma and chronic liver diseases. Sanc J Gastroenterol. 2014;49:1096–1102.
  • Harnack L, Jacobs DR, Nicodemus K, Lazovich DAnn, Anderson K, Folsom AR. Relationship of Folate, Vitamin B-6, Vitamin B-12, and Methionine Intake to Incidence of colorectal cancers. Nutr Cancer. 2002;43(2):152–158. doi:10.1207/S15327914NC432_5.
  • Bassett JK, Severi G, Hodge AM, Baglietto L, Hopper JL, English DR, Giles GG. Dietary intake of B vitamins and methionine and colorectal cancer risk. Nutr Cancer. 2013;65(5):659–667. doi:10.1080/01635581.2013.789114.
  • Fanidi A, Carreras-Torres R, Larose T, Yuan J, Stevens V, Weinstein S, et al. Is high vitamin B12 status a cause of lung cancer? Int J Cancer. 2019;145:1499–1593.
  • Rodríguez AMG, Velasco MJS, Melgosa IG, Fulgencio CV, Díaz FAA, Gómez ES. Hipervitaminosis B12 y mortalidad a edades avanzadas. Atención Fam. 2021;28:26–32.
  • Valdivia G, Navarrete C, Oñate A, Schmidt B, Fuentes R, Espejo E, et al. Asociación entre niveles de vitamina B-12 y mortalidad en pacientes hospitalizados adultos mayores. Rev Med Chil. 2020;148(1):46–53. doi:10.4067/S0034-98872020000100046.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.